Frontier Biotechnologies, Inc. (China)

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 949.82% vs 19.92% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 615.65% vs 20.83% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "297.10",
          "val2": "28.30",
          "chgp": "949.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "220.50",
          "val2": "-37.50",
          "chgp": "688.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.30",
          "val2": "2.40",
          "chgp": "-4.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "227.40",
          "val2": "-44.10",
          "chgp": "615.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "742.20%",
          "val2": "-1,688.00%",
          "chgp": "243.02%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -4.71% vs 13.40% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -33.12% vs 38.78% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "123.40",
          "val2": "129.50",
          "chgp": "-4.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-236.90",
          "val2": "-236.30",
          "chgp": "-0.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "10.00",
          "val2": "11.40",
          "chgp": "-12.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.50",
          "val2": "-11.20",
          "chgp": "95.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-268.10",
          "val2": "-201.40",
          "chgp": "-33.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,273.10%",
          "val2": "-2,151.50%",
          "chgp": "-12.16%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

297.10

28.30

949.82%

Operating Profit (PBDIT) excl Other Income

220.50

-37.50

688.00%

Interest

2.30

2.40

-4.17%

Exceptional Items

0.00

-0.20

100.00%

Consolidate Net Profit

227.40

-44.10

615.65%

Operating Profit Margin (Excl OI)

742.20%

-1,688.00%

243.02%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 949.82% vs 19.92% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 615.65% vs 20.83% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

123.40

129.50

-4.71%

Operating Profit (PBDIT) excl Other Income

-236.90

-236.30

-0.25%

Interest

10.00

11.40

-12.28%

Exceptional Items

-0.50

-11.20

95.54%

Consolidate Net Profit

-268.10

-201.40

-33.12%

Operating Profit Margin (Excl OI)

-2,273.10%

-2,151.50%

-12.16%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -4.71% vs 13.40% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -33.12% vs 38.78% in Dec 2024

All Annual Results